首页/数据集/FOLFOX 4 + CETUXIMAB IN UNTREATED PATIENTS WITH ADVANCED COLO-RECTAL TUMOUR. A PHASE II MULTICENTER STUDY OF THE GRUPPO ONCOLOGICO DELL’ITALIA MERIDIONALE

FOLFOX 4 + CETUXIMAB IN UNTREATED PATIENTS WITH ADVANCED COLO-RECTAL TUMOUR. A PHASE II MULTICENTER STUDY OF THE GRUPPO ONCOLOGICO DELL’ITALIA MERIDIONALE

NIAID Data Ecosystem2026-03-06 收录

结直肠癌临床试验

抗肿瘤药物疗效评估

数据链接：

https://www.omicsdi.org/dataset/ecrin-mdr-crc/2516472 数据链接链接失效反馈

官方服务：

资源简介：

Primary objectives: PERCENTAGE OF OBJECTIVE RESPONSES Primary endpoints: TO ESTIMATE THE PERCENTAGE OF OBJECTIVE RESPONSES

应用场景：

创建时间：

2004-12-15

抗肿瘤药物疗效评估

临床前动物模型

数据内容：肿瘤生长/抑瘤率、体重与一般状态、终点组织采样结果；成像数据与定量结果，并配套实验分组、给药方案、时间点、统计分析表与阶段性报告。采集方案：按肿瘤模型建立与给药方案制定采集计划；完整记录动物信息、分组随机化、给药剂量/途径/频次、观察与成像时间点、样本处理流程；

国家基础学科公共科学数据中心100

TINzaparin Prophylaxis in Patients With Metastatic Colorectal Cancer

癌症相关血栓

结直肠癌临床试验

Patients with metastatic colorectal cancer (mCRC) who are scheduled to receive systemic cancer therapy have an increased risk for venous thromboembolic (VTE) events compared with the general populatio

NIAID Data Ecosystem60

DMAMCL inhibition of intracranial C6 tumor growth.

抗肿瘤药物疗效评估

脑胶质瘤模型

Note: DMA-25, DMA-50, and DMA-100 represent DMAMCL at doses of 25, 50, and 100 mg/kg, respectively. Inhibition represents the percent decrease in tumor weight compared to the vehicle group. *p < 0.05,

NIAID Data Ecosystem50

An observational study of apatinib combined with XELOX regimen in postoperative adjuvant therapy of colorectal cancer

结直肠癌辅助化疗

抗肿瘤药物疗效评估

Interventions: experimental group:Apatinib combined with oxaliplatin and capecitabine (XELOX) g Primary outcome(s): Disease free survival Study Design: Single arm

NIAID Data Ecosystem80

A randomised controlled trial of the psychoneuroimmunological effects of relaxation and guided imagery, alone and in combination, in patients with colorectal cancer

癌症心理干预

结直肠癌临床试验

See http://cancerhelp.cancerresearchuk.org/trials/a-trial-looking-at-relaxation-therapy-and-guided-imagery-for-people-with-bowel-cancer

NIAID Data Ecosystem50